Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Assets (2017 - 2025)

Historic Return on Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 0.04%.

  • Collegium Pharmaceutical's Return on Assets fell 300.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.03% for FY2024, which is 100.0% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Return on Assets stood at 0.04%, which was down 300.0% from 0.02% recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Return on Assets high stood at 0.16% for Q2 2021, and its period low was 0.04% during Q3 2022.
  • Its 5-year average for Return on Assets is 0.04%, with a median of 0.04% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 1600bps in 2021, then tumbled by -1900bps in 2022.
  • Collegium Pharmaceutical's Return on Assets (Quarter) stood at 0.1% in 2021, then plummeted by -121bps to 0.02% in 2022, then skyrocketed by 297bps to 0.04% in 2023, then increased by 1bps to 0.04% in 2024, then fell by -13bps to 0.04% in 2025.
  • Its Return on Assets was 0.04% in Q3 2025, compared to 0.02% in Q2 2025 and 0.03% in Q1 2025.